Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection

The main expected result of a vaccine against viruses is the ability to produce neutralizing antibodies. Currently, several vaccines against SARS-CoV-2 are being applied to prevent mortal complications, being Pfizer-BioNTech (BNT162b2) one of the first to be authorized in the USA and Mexico (11 Dece...

Descripción completa

Detalles Bibliográficos
Autores principales: Morales-Núñez, José Javier, Muñoz-Valle, José Francisco, Meza-López, Carlos, Wang, Lin-Fa, Machado Sulbarán, Andrea Carolina, Torres-Hernández, Paola Carolina, Bedolla-Barajas, Martín, De la O-Gómez, Brenda, Balcázar-Félix, Paulina, Hernández-Bello, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310237/
https://www.ncbi.nlm.nih.gov/pubmed/34358158
http://dx.doi.org/10.3390/vaccines9070742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310237/
https://www.ncbi.nlm.nih.gov/pubmed/34358158
http://dx.doi.org/10.3390/vaccines9070742

Ejemplares similares